NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

AWH

Aspira Women's Health Inc

Apr 16 • 04:00PM ET

0.0820

Dollar change 0.0000
Percentage change 0.00	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: CDNA NTRA GH ILMN MYGN FLGT QDEL EXAS NEO DGX

| Held by: VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.99	Insider Own	28.50%	Shs Outstand	29.78M	Perf Week	-15.90%
Market Cap	2.44M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	21.30M	Perf Month	-29.97%
Income	-13.09M	PEG	-	EPS next Q	-	Inst Own	4.89%	Short Float	1.19%	Perf Quarter	-82.92%
Sales	9.18M	P/S	0.27	EPS this Y	-	Inst Trans	-30.20%	Short Ratio	0.05	Perf Half Y	-89.46%
Book/sh	-0.15	P/B	-	EPS next Y	-	ROA	-222.82%	Short Interest	0.25M	Perf Year	-97.58%
Cash/sh	0.06	P/C	1.38	EPS next 5Y	-	ROE	-	52W Range	0.08 - 3.57	Perf YTD	-88.37%
Dividend Est.	-	P/FCF	-	EPS past 5Y	18.89%	ROI	-	52W High	-97.70%	Beta	1.40
Dividend TTM	-	Quick Ratio	0.71	Sales past 5Y	16.25%	Gross Margin	59.67%	52W Low	6.49%	ATR (14)	0.02
Dividend Ex-Date	Jul 07, 2017	Current Ratio	0.76	EPS Y/Y TTM	44.72%	Oper. Margin	-177.28%	RSI (14)	30.68	Volatility	14.15% 14.40%
Employees	66	Debt/Eq	-	Sales Y/Y TTM	0.31%	Profit Margin	-142.61%	Recom	1.00	Target Price	5.50
Option/Short	No / No	LT Debt/Eq	-	EPS Q/Q	72.04%	Payout	-	Rel Volume	0.00	Prev Close	0.08
Sales Surprise	-17.30%	EPS Surprise	-8.70%	Sales Q/Q	10.28%	Earnings	Nov 14 BMO	Avg Volume	4.62M	Price	0.08
SMA20	-14.83%	SMA50	-51.49%	SMA200	-88.54%	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-22	Resumed	Cantor Fitzgerald	Overweight	$4
Mar-29-21	Initiated	Truist	Buy	$12
Jan-29-21	Initiated	Cantor Fitzgerald	Overweight	$10
Oct-30-20	Initiated	William Blair	Outperform

Apr-17-25 06:00AM	Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol 'AWHL' (ACCESSWIRE)
Apr-16-25 04:00PM	Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq (ACCESSWIRE) -12.49%
Apr-08-25 07:00AM	Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase Agreement (ACCESSWIRE)
Mar-31-25 08:00AM	Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award (ACCESSWIRE) -10.74%
Mar-27-25 04:00PM	Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results (ACCESSWIRE) +5.77%
08:00AM	Loading…
Mar-11-25 08:00AM	Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes (ACCESSWIRE) -11.62%
Feb-13-25 10:00AM	Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement (ACCESSWIRE) -9.97%
Feb-11-25 08:30AM	Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors (ACCESSWIRE) -20.18%
Jan-10-25 08:00AM	Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations (ACCESSWIRE) -9.89%
Dec-16-24 08:45AM	Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO (GlobeNewswire)
Dec-03-24 08:00AM	Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award (GlobeNewswire)
Nov-15-24 02:08AM	Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... (GuruFocus.com)
Nov-14-24 08:00AM	Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results (GlobeNewswire) -9.74%
Nov-13-24 07:34AM	Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Nov-07-24 08:00AM	Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch (GlobeNewswire)
08:00AM	Loading…
Nov-04-24 08:00AM	Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 (GlobeNewswire)
Oct-25-24 08:00AM	Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 (GlobeNewswire)
Oct-23-24 11:23AM	Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health (GlobeNewswire) -8.41%
Oct-15-24 04:05PM	Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch (GlobeNewswire) +15.93%
Sep-10-24 08:00AM	Aspira Women's Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass (GlobeNewswire)
Sep-06-24 08:00AM	Aspira Women's Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Sep-05-24 08:00AM	Aspira Women's Health Selected as a Spoke for the Investor Catalyst Hub (GlobeNewswire)
Aug-27-24 08:00AM	Aspira Women's Health Partners with Dorsata to Create New Clinical Workflow Tool for Adnexal Masses (GlobeNewswire) -5.05%
Aug-12-24 04:05PM	Aspira Women's Health Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 08:37AM	Aspira Women's Health's Announces a Poster Presentation at the 27th Annual National Association of Nurse Practitioners in Women's Health (NPWH) Women's Healthcare Conference (GlobeNewswire) -6.78%
Aug-01-24 08:00AM	Aspira Women's Health Announces Poster Presentation at the Menopause Society's 2024 Annual Meeting (GlobeNewswire)
Jul-31-24 04:05PM	Aspira Women's Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 12 (GlobeNewswire)
Jul-29-24 09:00AM	Aspira Women's Health Appoints Mr. John Ragard to its Board of Directors (GlobeNewswire)
Jul-11-24 08:00AM	Aspira Women's Health Announces Preliminary Second Quarter 2024 OvaSuite Product Volume and Highlights (GlobeNewswire) +7.63%
Jul-09-24 12:12PM	Aspira Women's Health Announces Closing of $1.9 Million Private Placement Equity Financing (GlobeNewswire) -6.45%
05:24PM	Loading…
Jul-01-24 05:24PM	Aspira Women's Health Announces $1.935 Million Private Placement Equity Financing (GlobeNewswire) -33.56%
Jun-13-24 08:00AM	Aspira Women's Health Provides Commercial, Reimbursement and Cash Guidance Updates (GlobeNewswire)
May-16-24 08:00AM	Aspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21 (GlobeNewswire) -5.04%
May-15-24 11:53AM	AWH Stock Earnings: Aspira Womens Health Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:40AM	Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Aspira Women's Health Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-08-24 08:47AM	UPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15 (GlobeNewswire)
08:00AM	Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15 (GlobeNewswire)
May-07-24 08:00AM	Aspira Women's Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts (GlobeNewswire) -8.10%
May-02-24 08:00AM	Aspira Women's Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch (GlobeNewswire)
Apr-09-24 08:00AM	Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California (GlobeNewswire) +9.93%
Apr-01-24 11:24AM	Aspira Women's Health Inc. (NASDAQ:AWH) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-28-24 11:53AM	AWH Stock Earnings: Aspira Womens Health Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -9.62%
07:30AM	Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-25-24 08:00AM	Aspira Women's Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call (GlobeNewswire)
Mar-21-24 08:00AM	Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference (GlobeNewswire)
Mar-18-24 08:00AM	Aspira Women's Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President (GlobeNewswire)
Mar-11-24 08:00AM	Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024 (GlobeNewswire)
Feb-22-24 08:30AM	Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference (GlobeNewswire) -5.36%
Feb-12-24 08:00AM	Aspira Womens Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI) (GlobeNewswire)
Feb-06-24 08:00AM	Aspira Women's Health Announces OvaSuite(SM) Distribution Agreement in the Philippines (GlobeNewswire)
Jan-25-24 08:00AM	Aspira Women's Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
07:30AM	OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape (GlobeNewswire)
Dec-19-23 08:00AM	Aspira Women's Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 (GlobeNewswire)
Dec-14-23 08:00AM	Aspira Women's Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024 (GlobeNewswire)
Dec-08-23 09:46AM	New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT (GlobeNewswire)
Dec-07-23 09:20AM	New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT (GlobeNewswire) +12.84%
Dec-06-23 08:00AM	Aspira Women's Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis (GlobeNewswire)
Nov-28-23 08:00AM	Aspira Women's Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal) (GlobeNewswire)
Nov-27-23 09:47AM	Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS) (GlobeNewswire)
Nov-13-23 04:05PM	Aspira Women's Health Reports Third Quarter 2023 Financial Results (GlobeNewswire) -8.82% -8.60%
Nov-09-23 08:00AM	Aspira Women's Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch (GlobeNewswire)
Oct-31-23 08:00AM	Aspira Womens Health to Announce Third Quarter Earnings Results and Host a Conference Call on Monday, November 13, 2023 (GlobeNewswire)
Oct-25-23 08:00AM	Aspira Women's Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research (GlobeNewswire) -7.08%
Oct-23-23 08:00AM	Aspira Women's Health Establishes a New Clinical Advisory Board (GlobeNewswire) -8.12%
Oct-20-23 10:43AM	New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT (GlobeNewswire)
Sep-29-23 08:00AM	Aspira Women's Health to Present at the BioVenture Nexus Conference (GlobeNewswire)
Sep-13-23 08:00AM	Aspira Womens Health Regains Nasdaq Compliance (GlobeNewswire) +23.34%
Sep-11-23 08:00AM	Aspira Womens Health Announces Dr. Jody Berry as New Chief Scientific Officer (GlobeNewswire)
Aug-31-23 08:00AM	Aspira Womens Health Signs Exclusive Sample Procurement Agreement with The University of Oxford (GlobeNewswire) +14.57%
Aug-29-23 08:00AM	Aspira Womens Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-28-23 08:00AM	Aspira Womens Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations (GlobeNewswire) +6.98%
Aug-14-23 04:01PM	Aspira Womens Health® Reports Second Quarter 2023 Financial Results (GlobeNewswire) -7.61%
Aug-09-23 04:05PM	Aspira Womens Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer (GlobeNewswire) +9.64%
Jul-31-23 08:00AM	Aspira Womens Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023 (GlobeNewswire)
Jul-20-23 08:30AM	Aspira Womens Health Announces $4.7 Million Registered Direct Offering (GlobeNewswire) -30.90%
Jun-28-23 08:00AM	Aspira Womens Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD (GlobeNewswire) +8.33%
Jun-12-23 06:23PM	New to The Street Announces Five Corporate Interviews on its 478th Show, Airing on the Fox Business Network, Tonight, Monday, June 12, 2023, at 10:30 PM PT (GlobeNewswire)
Jun-08-23 01:23PM	New to The Street TV Announces its Four Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT (GlobeNewswire)
01:23PM	New to The Street TV Announces its Five Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT (GlobeNewswire)
Jun-05-23 08:00AM	Aspira Womens Health Appoints Dr. Winfred Parnell to its Board of Directors (GlobeNewswire)
Jun-02-23 09:35AM	New to The Street Announces its Corporate Guests TV Interviews, Airing as Episodes 474 and 475 with Shows Starting on Saturday, June 3, 2023, at 3:30 PM ET (GlobeNewswire)
08:00AM	Aspira Womens Health Regained Compliance with Nasdaqs Minimum Bid Price Requirement (GlobeNewswire)
May-31-23 08:00AM	Aspira Womens Health Announces the Publication of Three Abstracts by the American Society of Clinical Oncology (ASCO) Supporting the Clinical Utility of OvaSuite(SM) Ovarian Cancer Risk Assessment Tests (GlobeNewswire)
May-30-23 08:00AM	Aspira Womens Health to Participate at William Blairs 43rd Annual Growth Stock Conference (GlobeNewswire) -6.00%
May-26-23 09:15AM	New to The Street Announces the Televised Lineups for Shows 471, 472, and 473; Airings on Three Networks Will Begin on Saturday, May 27, 2023, at 3:30 PM ET (GlobeNewswire) -6.42%
May-19-23 09:38AM	New to The Street Announces its Televised Corporate Interviews Airing on Newsmax and The FOX Business Network, Episodes 469 and 470; Broadcastings Begin Saturday, May 20, 2023, at 3:30 PM ET (GlobeNewswire)
08:00AM	Aspira Womens Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference (GlobeNewswire)
May-16-23 04:05PM	Aspira Womens Health Names Torsten Hombeck as Chief Financial Officer (GlobeNewswire)
May-15-23 04:05PM	Aspira Womens Health to Host Investor Day on OvaWatch(SM) and EndoCheck Market Opportunities on May 23, 2023 (GlobeNewswire) +15.88%
09:00AM	Aspira Womens Health launches its New to The Street Media Series on May 8, 2023, World Ovarian Cancer Day (GlobeNewswire)
May-11-23 04:01PM	Aspira Womens Health® Reports First Quarter 2023 Financial Results (GlobeNewswire) -13.87% -6.87%
12:33PM	Aspira Womens Health Announces 1-for-15 Reverse Stock Split (GlobeNewswire)
09:45AM	New to The Street Announces the Televised Lineups for Shows 466, 467, and 468; Airings on Three Networks, Starting Thursday, May 11, 2023, at 10:30 PM PT (GlobeNewswire)
08:00AM	Aspira Womens Health Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of microRNA-based Ovarian Cancer Test (GlobeNewswire)
May-09-23 04:07PM	Aspira Womens Health Appoints Three New Members to its Board of Directors (GlobeNewswire)
Apr-27-23 04:05PM	Aspira Womens Health Announces Preliminary First Quarter 2023 OvaSuite Volume Increase of 29% and Plans to Announce Full Earnings Results on May 11, 2023 (GlobeNewswire) +6.67%
Mar-27-23 07:12AM	Aspira Womens Health Inc. (NASDAQ:AWH) Q4 2022 Earnings Call Transcript (Insider Monkey) -11.70%
Mar-22-23 04:05PM	Aspira Womens Health Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -16.22%
Mar-03-23 08:38AM	Aspira Womens Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023 (GlobeNewswire) +19.14%

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vos Ellen O'Connor	Director	Mar 31 '25	Option Exercise	0.00	5,313	0	68,677	Apr 02 08:23 AM
Parnell Winfred	Director	Mar 31 '25	Option Exercise	0.00	5,156	0	66,053	Apr 01 09:01 PM
Beausang Ellen	Director	Mar 31 '25	Option Exercise	0.00	1,615	0	1,615	Apr 01 08:59 PM
Cavanaugh Stefanie L.	Director	Mar 31 '25	Option Exercise	0.00	5,938	0	72,789	Apr 01 06:42 PM
Ragard John Phillip	Director	Mar 31 '25	Option Exercise	0.00	4,843	0	129,890	Apr 01 06:42 PM
Herchuk Jannie Prestridge	Director	Mar 31 '25	Option Exercise	0.00	8,438	0	74,065	Apr 01 06:42 PM
Fralick Celeste Rachelle	Director	Mar 31 '25	Option Exercise	0.00	5,000	0	55,665	Apr 01 06:42 PM
Herchuk Jannie Prestridge	Director	Dec 31 '24	Option Exercise	0.00	8,437	0	65,627	Jan 08 07:20 PM
Fralick Celeste Rachelle	Director	Dec 31 '24	Option Exercise	0.00	5,000	0	50,665	Jan 08 07:12 PM
Parnell Winfred	Director	Dec 31 '24	Option Exercise	0.00	5,157	0	60,897	Jan 08 07:05 PM
Cavanaugh Stefanie L.	Director	Dec 31 '24	Option Exercise	0.00	5,937	0	66,851	Jan 08 06:58 PM
Ragard John Phillip	Director	Dec 31 '24	Option Exercise	0.00	4,844	0	125,047	Jan 08 06:47 PM
Milligan Sandra	Interim CEO & President	Dec 31 '24	Option Exercise	0.00	20,000	0	20,000	Jan 08 06:35 PM
Vos Ellen O'Connor	Director	Dec 31 '24	Option Exercise	0.00	5,312	0	63,364	Jan 08 06:17 PM
Vos Ellen O'Connor	Director	Sep 30 '24	Option Exercise	0.00	5,313	0	58,052	Oct 03 04:44 PM
Cavanaugh Stefanie L.	Director	Sep 30 '24	Option Exercise	0.00	5,938	0	60,914	Oct 02 06:05 PM
Parnell Winfred	Director	Sep 30 '24	Option Exercise	0.00	5,156	0	55,740	Oct 02 05:55 PM
Herchuk Jannie Prestridge	Director	Sep 30 '24	Option Exercise	0.00	8,438	0	57,190	Oct 02 05:39 PM
Ragard John Phillip	Director	Sep 30 '24	Option Exercise	0.00	4,844	0	120,203	Oct 02 05:31 PM
Fralick Celeste Rachelle	Director	Sep 30 '24	Option Exercise	0.00	5,000	0	45,665	Oct 02 05:19 PM
Sandford Nicole	Chief Executive Officer	May 31 '24	Buy	2.42	9,493	22,973	70,596	Jun 03 05:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AWH

Aspira Women's Health Inc

Upgrade your FINVIZ experience